Halo phenomenon: literature review and rare clinical cases


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Halo phenomenon is described as a rim of depigmentation around a variety of skin lesions with different histogenesis. Most frequently it has been reported in cases of melanocytic nevi with an estimated frequency of 1%. Focal depigmentation of hair (leukotrichia, poliosis) represents the rare clinical presentations of halo phenomenon and can be the only clinical sign of halo nevi. A case-report of halo nevus, located on the scalp and manifested by local leukotrichia, as well as report of halo phenomenon around the nevus sebaceous of Jadassohn are described in the article. A review of the literature on halo phenomenon is given in the article, differential diagnosis of leukotrichia is discussed.

Full Text

Restricted Access

About the authors

V. V Mordovtseva

Moscow State University of Food Production

Yu. Yu Sergeev

Society of Dermatoscopy and Optical Skin Diagnostics

Email: tosergeev@gmail.com
Member of the Board

References

  1. Sutton R.L. An unusual variety of vitiligo (Leukoderma centrifugum acquisitum). J. Cutan. Dis. 1916;34:797.
  2. Herba F., Kaposi M. Diseases of the skin. London, The New Sydenham Society, 1874;3:180.
  3. Feldman S., Lashinsky I.M. Halo nevus. Leukoderma centrifugum acquisitum (Sutton); leukopigmentary nevus. Arch. Derm. Syphilol. 1936;34(4):590-604. Doi: 10.1001/ archderm.1936.01470160037005.
  4. Цветкова Г.М., Мордовцева В.В., Вавилов А.М., Мордовцев В.Н. Патоморфология болезней кожи. Руководство для врачей. М., 200. С. 326-27.
  5. Hung C.T., Chiang C.P. Solitary tumor with a peripheral depigmented patch and poliosis. Indian J. Dermatol. Venereol. Leprol. 2012;78(6):776. doi: 10.4103/0378-6323.102402.
  6. Larre Borges A., Zalaudek I., Longo C., Dufrechou L., Argenziano G., Lallas A., Piana S., Moscarella E. Melanocytic nevi with special features: clinical-dermoscopic and reflectance confocal microscopic-findings. J. Eur. Acad. Dermatol. Venereol. 2014;28(7):833-45. Doi: 10.1111/ jdv.12291.
  7. Babu A., Bhat M.R., Dandeli S., Ali N.M. Throwing light onto the core of a halo nevus: a new finding. Indian J. Dermatol. 2016;61:238. doi: 10.4103/0019-5154.177801.
  8. Aouthmany M., Weinstein M., Zirwas M.J., Brodell R.T. The natural history of halo nevi: a retrospective case series. J. Am. Acad. Dermatol. 2012;67 (4):582-6. Doi: 10.1016/j. jaad.2011.11.937.
  9. Mooney M.A., Barr R.J., Buxton M.G. Halo nevus or halo phenomenon? A study of 142 cases. J. Cutan. Pathol. 1995;22:342-8. Doi: 10.1111/ j.1600-0560.1995.tb01417.x.
  10. Сергеев Ю.В. Будни дерматолога. М., 2012. 668 с.
  11. Suzuki N., Dalapicola M., Argenziano G., Lallas A., Longo C., Piana S., Ferrara G., Raucci M., Moscarella E. Halo and pseudo-halo melanoma. J. Am. Acad. Dermatol. 2016;74(4):e59-61. doi: 10.1016/j.jaad.2015.09.027.
  12. Сергеев Ю.Ю., Мордовцева В.В. Меланома кожи с явлениями регресса: описание клинического случая и обзор литературы. Клиническая дерматология и венерология. 2017;16 (5):36-41. Doi: 10.17116/ klinderma201716536-41.
  13. Rongioletti F., Cecchi F., Rebora A. Halo phenomenon in melanocytic nevi (Sutton's nevi). Does the diameter matter? J. Eur. Acad. Dermatol. Venereol. 2011;25(10):1231-32. doi: 10.1111/j.1468-3083.2010.03790.x.
  14. Kolm I., Di Stefani A., Hofmann-Wellenhof R., Fink-Puches R., Wolf I.H., Richtig E., Smolle J., Kerl H., Soyer H.P, Zalaudek I. Dermoscopy patterns of halo nevi. Arch. Dermatol. 2006;142(12):1627-32. Doi:10.1001/ archderm.142.12.1627.
  15. Kamihska-Winciorek G., Szymszal J. Dermoscopy of halo nevus in own observation. Advances in Dermatology and Allergology/ Postepy Dermatologii i Alergologii. 2014; 31(3):152-58. doi: 10.5114/pdia.2014. 40963.
  16. Bayer-Garner I.B., Ivan D., Schwartz M.R., Tschen J.A. The immunopathology of regression in benign lichenoid keratosis, keratoacanthoma and halo nevus. Clin. Med. Res. 2004; 2(2):89-97.
  17. Zeff R.A., Freitag A., Grin C.M., Grant-Kels J.M. The immune response in halo nevi. J. Am. Acad. Dermatol. 1997;37:620-24. Doi: 10.1016/ S0190-9622(97)70181-6.
  18. Weyant G.W., Chung C.G., Helm K.F. Halo nevus: review of the literature and clinicopathologic findings. Int. J. Dermatol. 2015;54(10):e433-35. doi: 10.1111/ijd.12843.
  19. Nedelcu R.I., Zurac S.A., Brînzea A., Cioplea M.D., Turcu G., Popescu R., Popescu C.M., Ion D.A. Morphological features of melanocytic tumors with depigmented halo: review of the literature and personal results. Rom. J. Morphol. Embryol. 2015;56(Suppl. 2):659-63.
  20. Young L.C., Van Dyke G.S., Lipton S., Binder S.W. Poliosis overlying a nevus with blue nevus features. Dermatol. Online J. 2008;14(2):20.
  21. Walker S., Lucke T.W., Burden A.D., Thomson J. Poliosis circumscripta associated with scalp naevi: a report of four cases. Br. J. Dermatol. 1999;140(6):1182-84.
  22. Gutte R., Khopkar U. Extralesional vitiligo over knee following halo nevus with poliosis on the scalp. Indian J. Dermatol. Venereol. Leprol. 2011;77:522-25. doi: 10.4103/03786323.82397.
  23. Kay K.M., Kim J.H., Lee T.S. Poliosis of eyelashes as an unusual sign of a halo nevus. Korean J. Ophthalmol. 2010;24 (4):237-39. doi: 10.3341/kjo.2010.24.4.237.
  24. Vainstein G., Nemet A.Y. Unilateral poliosis of eyelashes. Ophthal. Plast. Reconstr. Surg. 2016;32(3):e73-4. Doi: 10.1097/ IOP0000000000000250.
  25. Sleiman R., Kurban M., Succaria F., Abbas O. Poliosis circumscripta: overview and underlying causes. J. Am. Acad. Dermatol. 2013;69(4):625-33. Doi: 10.1016/j. jaad.2013.05.022.
  26. Herd R.M., Hunter J.A. Familial halo naevi. Clin. Exp. Dermatol. 1998;23:68-9.
  27. Albert D.M., Todes-Taylor N., Wagoner M., Nordlund J.J., Lerner A.B. Vitiligo or halo nevi occurring in two patients with choroidal melanoma. Arch. Dermatol. 1982; 118(1):34-6.
  28. Kawaguchi A., Yamamoto T., Okubo Y., Mitsuhashi Y., Tsuboi R. Multiple halo nevi subsequent to a short period of sunbathing. J. Dermatol. 2015;42(5):543-44. doi: 10.1111/1346-8138.12814.
  29. Kuet K., Goodfield M. Multiple halo naevi associated with tocilizumab. Clin. Exp. Dermatol. 2014;39(6):717-19. Doi: 10.1111/ ced.12385.
  30. Maruthappu T., Leandro M., Morris S.D. Deterioration of vitiligo and new onset of halo naevi observed in two patients receiving adalimumab. Dermatol. Ther. 2013;26(4):370-72. doi: 10.1111/dth.12002.
  31. Dereure O., Guillon F., Guillot B., Guilhou J.J. Multiple halo naevi associated with carcinoid in a young man. Acta Derm. Venereol. 2004;84(6):495-96. doi: 10.1080/00015550410020430.
  32. Cohen B.E., Mu E.W., Orlow S.J. Comparison of childhood vitiligo presenting with or without associated halo nevi. Pediatr. Dermatol. 2016;33(1):44-8. doi: 10.1111/pde.12717.
  33. Schallreuter K.U., Kothari S., Elwary S., Rokos H., Hasse S., Panske A. Molecular evidence that halo in Sutton's naevus is not vitiligo. Arch. Dermatol. Res. 2003;295:223-28. Doi: 10.1007/ s00403-003-0427-2.
  34. De Vijlder H.C., Westerhof W., Schreuder G.M.Th., De Lange P., Claas F.H.J. Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment. Cell. Research. 2004;17:270-74. doi: 10.1111/j.1600-0749.2004.00145.x.
  35. Patrizi A., Bentivogli M., Raone B., Dondi A., Tabanelli M., Neri I. Association of halo nevus/i and vitiligo in childhood: a retrospective observational study. J. Eur. Acad. Dermatol. Venereol. 2013;27:e148-e52. doi: 10.1111/j.1468-3083.2012.04504.x.
  36. Scope A., Marghoob A.A., Chen C.S., Lieb J.A., Weinstock M.A., Halpern A.C. Dermoscopic patterns and subclinical melanocytic nests in normal-appearing skin. British J. Dermatol. 2009;160:1318-21. doi: 10.1111/j.1365-2133.2009.09073.x.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies